Chemists at the University of Geneva and University of Pisa have crafted a novel family of chiral molecules whose mirror-image “handedness” remains rock-solid for tens of thousands of years. By ...

Our galaxy may reside in a billion-light-year-wide cosmic bubble that accelerates local expansion, potentially settling the ...

Kids who consume artificial and natural sweeteners like aspartame, sucralose, and glycyrrhizin may face an increased risk of ...

Obesity-related cancer deaths in the U.S. have tripled in just two decades, with women, older adults, and minority groups ...

Hubble’s crystal-clear look at NGC 1786—an ancient globular cluster tucked inside the Large Magellanic Cloud—pulls us 160,000 ...

Gravitational-wave detectors have captured their biggest spectacle yet: two gargantuan, rapidly spinning black holes likely ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older adults. A small study found that up to 40% of weight loss from semaglutide ...